X0306 4 2016-01-08 0001053691 RestorGenex Corp RESX 0001663220 Byrne Thomas S 2020 AVON COURT, SUITE 4 CHARLOTTESVILLE VA 22902 1 Common Stock 2016-01-08 4 A 0 1391867 A 1391867 D Stock Option (Right to Buy) 0.22 2016-01-08 4 A 0 215506 0 A 2012-05-17 2022-05-17 Common Stock 215506 215506 D Stock Option (Right to Buy) 0.22 2016-01-08 4 A 0 91316 0 A 2022-10-09 Common Stock 91316 91316 D Stock Option (Right to Buy) 0.22 2016-01-08 4 A 0 109579 0 A 2022-10-09 Common Stock 109579 109579 D Stock Option (Right to Buy) 0.35 2016-01-08 4 A 0 36526 0 A 2023-10-05 Common Stock 36526 36526 D Stock Option (Right to Buy) 0.62 2016-01-08 4 A 0 182632 0 A 2023-10-05 Common Stock 182632 182632 D Stock Option (Right to Buy) 0.42 2016-01-08 4 A 0 182632 0 A 2024-12-01 Common Stock 182632 182632 D Stock Option (Right to Buy) 0.42 2016-01-08 4 A 0 182632 0 A 2024-12-01 Common Stock 182632 182632 D Stock Option (Right to Buy) 0.55 2016-01-08 4 A 0 365265 0 A 2025-10-30 Common Stock 365265 365265 D Stock Option (Right to Buy) 0.55 2016-01-08 4 A 0 237422 0 A 2025-10-30 Common Stock 237422 237422 D Received in exchange for 381,056 units of Diffusion Pharmaceuticals LLC ("Diffusion") in connection with the consummation of the merger (the "Merger") of Diffusion and a wholly-owned subsidiary of the Issuer ("Merger Sub") on January 8, 2016 based upon the exchange rate set forth in the Agreement and Plan of Merger, dated December 15, 2015, by and among the Issuer, Diffusion and Merger Sub. In connection with the consummation of the Merger, an option originally granted on May 17, 2012 to purchase membership units in Diffusion was converted into an option to purchase common stock of the Issuer. In connection with the consummation of the Merger, an option originally granted on October 9, 2012 to purchase membership units in Diffusion was converted into an option to purchase common stock of the Issuer. The shares underlying the options vest in equal parts each month until fully vested on the third anniversary of the grant date. In connection with the consummation of the Merger, an option originally granted on October 5, 2013 to purchase membership units in Diffusion was converted into an option to purchase common stock of the Issuer. In connection with the consummation of the Merger, an option originally granted on December 1, 2014 to purchase membership units in Diffusion was converted into an option to purchase common stock of the Issuer. In connection with the consummation of the Merger, an option originally granted on October 30, 2015 to purchase membership units in Diffusion was converted into an option to purchase common stock of the Issuer. /s/ Ben Shealy, attorney-in-fact for Thomas Byrne 2016-01-12